About Augurex
Augurex is a company based in Vancouver (Canada) founded in 2006.. Augurex has raised $978.2 thousand across 3 funding rounds from investors including WUTIF. Augurex offers products and services including Biomarker Tests and Diagnostic Solutions. Augurex operates in a competitive market with competitors including Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and BillionToOne, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Augurex Life Sciences Corp.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$978.2 K (USD)
in 3 rounds
-
Latest Funding Round
$25.2 K (USD), Seed
Feb 01, 2011
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Augurex
Augurex offers a comprehensive portfolio of products and services, including Biomarker Tests and Diagnostic Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tests for early detection and management of rheumatoid arthritis.
Tools for diagnosing and monitoring axial spondyloarthritis conditions.
Unlock access to complete
Unlock access to complete
Funding Insights of Augurex
Augurex has successfully raised a total of $978.2K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $25.2 thousand completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $25,200
-
First Round
First Round
(01 Nov 2007)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2011 | Amount | Seed - Augurex | Valuation |
investors |
|
| May, 2009 | Amount | Seed - Augurex | Valuation |
investors |
|
| Nov, 2007 | Amount | Seed - Augurex | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Augurex
Augurex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include WUTIF. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology startups in British Columbia are funded by WUTIF.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Augurex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Augurex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Augurex Comparisons
Competitors of Augurex
Augurex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and BillionToOne, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Augurex
Frequently Asked Questions about Augurex
When was Augurex founded?
Augurex was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Where is Augurex located?
Augurex is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Is Augurex a funded company?
Augurex is a funded company, having raised a total of $978.2K across 3 funding rounds to date. The company's 1st funding round was a Seed of $900K, raised on Nov 01, 2007.
What does Augurex do?
Augurex was founded in 2006 in Vancouver, Canada, within the biotechnology sector focused on medical diagnostics. Tests are developed to identify autoimmune and chronic conditions, with operations centered on protein biomarker analysis. The flagship product, JOINTstat, quantifies serum levels of 14-3-3η protein in patients suspected of rheumatoid arthritis. Elevated levels are linked to increased disease risk, supporting clinical decisions on joint monitoring frequency.
Who are the top competitors of Augurex?
Augurex's top competitors include Guardant Health, GRAIL and BillionToOne.
What products or services does Augurex offer?
Augurex offers Biomarker Tests and Diagnostic Solutions.
Who are Augurex's investors?
Augurex has 1 investor. Key investors include WUTIF.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.